Clincosm LogoSign in Get a demo

Outpatient Oncology Aromatherapy for Symptom Management

Sponsor
Central DuPage Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04449315
Collaborator
(none)
40
Enrollment
1
Location
1
Arm
10
Anticipated Duration (Months)
4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this research study is to determine whether using aromatherapy during chemotherapy infusion treatments in the outpatient Oncology setting promote relief of nausea and anxiety.

The objectives of this study are: 1. To promote relief of nausea using peppermint aromatherapy oil in an outpatient oncology setting. 2. To promote relief of anxiety using lavender aromatherapy oil in an outpatient oncology setting.

Condition or Disease Intervention/Treatment Phase
  • Other: Young Living Lavender Essential Oil
 N/A

Detailed Description

Subject Selection: Every outpatient oncology patient experiencing nausea and/or anxiety during an infusion visit will be offered hospital-approved aromatherapy of Peppermint oil or Lavender oil. If patient says yes, then they will be selected for the study and infusion nurse will notify the study co-investigators or principal investigator. Informed consent will then be obtained by co-investigators or principal investigator of the study. The consents as well as the data collection tool sheets will be numbered without identifying patient's personal information. Peppermint oil aromatherapy and/or lavender oil aromatherapy will then be administered to consented patients.

Method of Subject Identification and Recruitment: Every outpatient oncology patient experiencing nausea and/or anxiety during an infusion visit will be offered hospital- approved aromatherapy of Peppermint oil or Lavender oil. If patient says yes, then they will be selected for the study and infusion nurse will notify the study co-investigators or principal investigator. Informed consent will then be obtained by co-investigators or principal investigator of the study. The consents as well as the data collection tool sheets will be numbered without identifying patient's personal information. Peppermint oil aromatherapy and/or lavender oil aromatherapy will then be administered to consented patients.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Outpatient Oncology Aromatherapy
Anticipated Study Start Date :
Aug 1, 2020
Anticipated Primary Completion Date :
May 1, 2021
Anticipated Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Peppermint and Lavender Essential Oil

Young Living Essential oil of Peppermint and Lavender will be used to patients who meet the inclusion criteria.

Other: Young Living Lavender Essential Oil
For qualified patients one to two drops of hospital approved essential oil will be placed on a 4X4 gauze and will be offered to the patient during their infusion visit. This gauze will be placed in a sealable clear plastic bag and the patient will be instructed to use one sniff at a time.
Other Names:
  • Young Living Peppermint Essential Oil

    		•

    Outcome Measures

    Primary Outcome Measures

    1. Post Intervention Interview From [Immediately upon Completion of the patient's infusion]

      After the patients' infusion they will be asked questions from this form

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    All outpatient Oncology patients > 18 years of age Non pregnant Not cognitively impaired English speaking only Patients who report nausea and/or anxiety

    Exclusion Criteria:

    All outpatient oncology patients <18 years of age Pregnant Cognitively impaired Non-English Speaking Patients who do not report nausea and/or anxiety Patients with a known allergy to peppermint and/or lavender aromatherapy oil

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Central DuPage Winfield Illinois United States 60190

    Sponsors and Collaborators

    • Central DuPage Hospital

    Investigators

    • Principal Investigator: Lorraine Mack, MSN, Central DuPage Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Central DuPage Hospital
    ClinicalTrials.gov Identifier:
    NCT04449315
    Other Study ID Numbers:
    • CentralDuPage
    First Posted:
    Jun 26, 2020
    Last Update Posted:
    Jun 26, 2020
    Last Verified:
    Jun 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Additional relevant MeSH terms:
    Nausea

    Study Results

    No Results Posted as of Jun 26, 2020